Skip to main content

SCHIVO 3D

ServiceWaterford, IrelandFounded 1973· One of 1986 Service companies tracked by AMPulse

Provides ISO 13485-certified industrial 3D printing and precision engineering services, specializing in DMLS metal and FDM polymer manufacturing for regulated medical, aerospace, and industrial sectors.

CEO / Founder
Graham Reeves
Team Size
501-1000
Stage
Active
Total Funding
$47.1M
Latest Round
Strategic Investment
Key Investors
Bank of Ireland (BOI); MML Capital Partners; Dunport Capital Management; Five Arrows (Rothschild & Co); Ian Quinn

Technology & Products

Key Products

Schivo produces integrated vessel cutting tools, cannulas, and components for robotic-assisted surgery systems, minimally invasive surgical devices, and cardiovascular and endo-mechanical systems.

Technological Advantage

Claimed: End-to-end manufacturing capability with rapid turnaround and strict quality control. Verified: Deployment of EOS INT M 280 DMLS system, Stratasys FDM partnership, and ISO 13485 certification. Defensible: High regulatory compliance barrier and integrated workflow create significant switching costs for medical/aerospace clients.

Differentiation

Value Proposition

Reduces supply chain complexity and lead times by offering a fully vertically integrated, ISO 13485-certified manufacturing solution that combines AM, CNC machining, and final assembly under one roof.

How They Differentiate

Unlike global on-demand platforms (Xometry, Protolabs), SCHIVO 3D operates as a dedicated, vertically integrated contract manufacturer with deep regulatory expertise (ISO 13485) and localized engineering support in Ireland/UK, offering tighter quality control and direct assembly capabilities for highly regulated components.

Market & Competition

Target Customers

Medical device manufacturers, aerospace OEMs, and industrial engineering firms requiring certified, low-to-medium volume production and rapid prototyping.

Industry Verticals

Medical Devices; Aerospace; Analytical Instrumentation; Process Control; Oil & Gas

Competitors

Protolabs; Materialise; Xometry

Growth & Milestones

Growth Metrics

630+ employees across 7 global facilities in Europe, North America, and Asia; fully vertically integrated lean manufacturing and supply chain capability serving regulated medical, aerospace, and industrial sectors.

Major Milestones

2015: Launched FDM 3D printing partnership with Stratasys; Deployed EOS INT M 280 DMLS system for metal additive manufacturing; Achieved ISO 13485 certification for medical device manufacturing; Expanded to three operational facilities across Waterford (Ireland) and Leicester (UK); September 2025: Acquired Mecaplast SA, Swiss precision injection molding company

Notable Customers

Schivo supports major medical device companies such as Intuitive, Medtronic, Boston Scientific-Apollo, Stryker, and Avitus Zimmer Biomet.

https://www.schivomedical.com

Why this company matters

SCHIVO 3D occupies a distinct position in the additive manufacturing service landscape as a vertically integrated contract manufacturer rather than a digital quoting platform. Founded in 1973 and based in Waterford, Ireland, the company has evolved from traditional precision engineering into a full-spectrum manufacturing partner that combines metal and polymer AM with CNC machining and final assembly. Its ISO 13485 certification for medical devices creates a high regulatory barrier that differentiates it from general-purpose on-demand platforms like Xometry or Protolabs.

The company's core technology stack includes DMLS via an EOS INT M 280 system for metal parts and FDM through a strategic partnership with Stratasys for polymer production. These capabilities support low-to-medium volume production of components such as integrated vessel cutting tools, cannulas, and parts for robotic-assisted surgery systems, minimally invasive surgical devices, and cardiovascular and endo-mechanical systems. SCHIVO 3D serves medical device OEMs including Intuitive, Medtronic, Boston Scientific-Apollo, Stryker, and Avitus Zimmer Biomet, as well as aerospace and industrial clients.

SCHIVO 3D's strategic moat rests on its combination of regulatory certification, multi-process manufacturing under one roof, and localized engineering support across three facilities in Ireland and the UK. The company has raised $47.1 million from investors including Bank of Ireland, MML Capital Partners, and Five Arrows. A key open question is whether its regional focus in Ireland and the UK limits scalability compared to global platforms, or whether deep regulatory expertise and switching costs for medical and aerospace clients provide durable competitive insulation.

The company's partnership with the Waterford Institute of Technology's SEAM research center suggests ongoing engagement with AM process development. With over 200 employees and a CEO who previously led Merlion Medical Partners, SCHIVO 3D is positioned to serve clients that require certified, traceable production rather than rapid, low-cost prototyping.